5 Best Sliver Stocks To Own Right Now

Yesterday, shares of Monro Muffler Brake (MNRO) plunged 3.1% after Barron’s Leslie Norton panned the stock in this weekend’s issue of the magazine. And wouldn’t you know it? Monro’s shares are skidding lower once again today.

Mike Mozart/JeepersMedia

Norton’s argument was straightforward:

At a recent $62, Rochester, N.Y.based Monro (ticker: MNRO) trades at a lofty 28 times forward earnings, compared with a 10-year average of 21.1, and 17 times earnings for the Standard & Poors 500. With sales growth slowing as competition increases, Monros strategic goal of achieving 15% annual sales gains and 20% profit growth seems distant.

Any hint of more sluggish sales could push the shares down at least 10%. Bruce Geller, CEO of money manager Dalton Greiner Hartman Maher, who is short the stock, says, A fairly commoditized business with low organic growth deserves a more reasonable multiple of 20 times.

5 Best Sliver Stocks To Own Right Now: Vanguard Short-Term Corporate Bond ETF(VCSH)

Vanguard Short Term Corporate Bond ETF (the Fund) seeks to track the performance of a market-weighted corporate bond index with a short-term, dollar-weighted average maturity. The Fund employs a passive management or indexing investment approach designed to track the performance of the Barclays Capital U.S. 1-5 Year Corporate Index (the Index). This Index includes the United States dollar-denominated, investment-grade, fixed-rate, taxable securities issued by industrial, utility and financial companies, with maturities between 1 and 5 years. The Fund invests by sampling the Index, meaning that it holds a range of securities that, in the aggregate, approximates the full Index in terms of key risk factors and other characteristics. All of the Funds investments will be selected through the sampling process, and at least 80% of the Funds assets will be invested in bonds included in the Index. The Funds investment advisor is Vanguard Fixed Income Group. Advisors’ Opinion:

  • [By Steven Goldberg]

    Youll never grow rich owning Vanguard Short-Term Corporate Bond ETF (VCSH), but you wont go broke, either. I especially love two numbers about this fund: its annual expense ratio of just 0.10% and its average duration of 2.8 years (duration is a measure of interest-rate sensitivity; a duration of 2.8 years suggests that the funds price would drop by 2.8% if interest rates rose by one percentage point). The exchange-traded fund invests in short-term, high-quality corporate and government bonds. It yields just 1.9%, but the modest payout is a fair trade-off for the low risk.

5 Best Sliver Stocks To Own Right Now: Westar Energy, Inc.(WR)

Westar Energy, Inc. (Westar Energy), incorporated on March 6, 1924, is an electric utility in Kansas. The Company provides electric generation, transmission and distribution services to approximately 700,000 customers in Kansas. The Company provides these services in central and northeastern Kansas, including the cities of Topeka, Lawrence, Manhattan, Salina and Hutchinson. Kansas Gas and Electric Company (KGE), Westar Energy’s subsidiary, provides the services in south-central and southeastern Kansas, including the city of Wichita. Both Westar Energy and KGE conduct business using the name Westar Energy. The Company supplies electric energy at retail to customers in Kansas. The Company also supplies electric energy at wholesale to municipalities and electric cooperatives in Kansas, and has contracts for the sale or purchase of wholesale electricity with other utilities. The Company classifies it customers as residential, commercial and industrial. It has approximately 6,2 70 megawatts (MW) of generating capacity in service.

Fossil Fuel Generation

The three coal-fired units at Jeffrey energy center have an aggregate capacity of approximately 2,150 MW, of which the Company owns or consolidate through a variable interest entity (VIE) a combined share, or over 1,970 MW. The two coal-fired units at La Cygne Generating Station (La Cygne) have an aggregate generating capacity of approximately 1,400 MW, of which the Company owns or consolidate, through a VIE. La Cygne uses primarily Powder River Basin (PRB) coal but one of the two units also uses a small portion of locally mined coal. Lawrence and Tecumseh Energy Centers have an aggregate generating capacity of approximately 540 MW.

Natural Gas

The Company uses natural gas as a primary fuel at its Gordon Evans, Murray Gill, Hutchinson, Spring Creek and Emporia Energy Centers and at the State Line facility. The Company also uses natural gas as a supp lemental fuel in the coal-fired units at Lawrence and Tecums! eh Energy Centers.

Diesel

The Company uses diesel to start some of its coal generating stations, as a primary fuel in the Hutchinson No. 4 combustion turbine and in its diesel generators. The Company also purchases No. 2 diesel in the spot market.

Nuclear Generation

Wolf Creek is approximately 1,170 MW nuclear power plant located near Burlington, Kansas. KGE owns an interest in Wolf Creek, or approximately 550 MW.

Wind Generation

The Company owns approximately 150 MW of designed installed wind capacity. Also of the approximately 1,310 MW of wind power under contract, the Company has over 910 MW in operation.

Advisors’ Opinion:

  • [By Lisa Levin]

    On Thursday, utilities shares rose by 0.02 percent. Top gainers in the sector included Westar Energy Inc (NYSE: WR), Westar Energy Inc (NYSE: AT), and NRG Energy Inc (NYSE: NRG).

  • [By Jayson Derrick]

    According to a report by Bloomberg, Westar Energy Inc (NYSE: WR) is a potential takeover target from rival Ameren Corp (NYSE: AEE) and a consortium of investors, including Toronto-based Borealis Infrastructure Management and the Canada Pension Plan Investment Board.

Top Building Product Stocks To Own For 2016: Liberty Interactive Corporation(QVCA)

Liberty Interactive Corporation, incorporated on February 28, 2006, owns interests in subsidiaries and other companies, which are primarily engaged in the video and online commerce industries. Through its subsidiaries and affiliates, the Company operates in North America, Europe and Asia. The Company’s principal businesses and assets include its subsidiaries QVC, Inc. (QVC), zulily, llc (zulily), Bodybuilding.com, LLC (Bodybuilding) and CommerceHub and Evite, Inc. (Evite). The Company’s segments include QVC, zulily, and Corporate and other.

Bodybuilding is an e-retailer of nutritional and dietary supplements. Bodybuilding also hosts an online health and fitness publication, offering free daily fitness content, workouts, video-based training plans, recipes, health advice and motivational stories. The online e-retail model combines detailed product information and real-time user reviews on approximately 15,000 health and fitness supplements and accessories.

< p>

CommerceHub provides a cloud-based e-commerce fulfillment and marketing software platform of integrated supply, demand and delivery solutions for large retailers, online marketplaces and digital marketing channels, as well as consumer brands, manufacturers, distributors and other market participants. CommerceHub’s software platform acts as a hub that allows trading partners to conduct omni-channel commercial relationships in consumer and business-to-business e-commerce markets. Approximately 9,500 trading partners have access to CommerceHub’s platform daily to exchange critical information with each other, including orders, invoices, product information and other electronic documents. Evite is an online invitation and social event planning service on the Web. In addition to invitations, Evite also offers party ideas, planning checklists and other tools.

QVC

QVC markets and sells a range of consumer products primarily through live merchandis e-focused televised shopping programs distributed to approxi! mately 360 million households each day and through its Websites, including QVC.com, and other interactive media, such as mobile applications. In the United States, QVC distributes its programming live 24 hours per day, 364 days per year and presents on over 770 products every week. Internationally, QVC distributes live programming 8 to 24 hours per day, depending on the market. QVC classifies its products into over six groups: home, beauty, apparel, jewelry, accessories and electronics. QVC’s televised shopping programs reached approximately 140 million television households outside of the United States, primarily in Germany, Austria, Japan, the United Kingdom, the Republic of Ireland, Italy and France. In addition, QVC’s joint venture in China reached approximately 110 million homes. Internationally, QVC-International also broadcasts pre-recorded shows on additional channels that offer viewers access to a range of QVC programming options. These channels include QVC Beauty & Style and QVC Plus in Germany and QVC Beauty, QVC Extra, QVC Style and QVC +1 in the United Kingdom.

QVC distributes its television programs, through satellite and optical fiber, to cable television and direct-to-home satellite system operators for retransmission to their subscribers in the United States, Germany, Japan, the United Kingdom, France and neighboring countries. In the United States, QVC uplinks its analog and digital programming transmissions using a third-party service. QVC’s Web and mobile platforms are integrated with its televised programming and product distribution capabilities.

Zulily

Zulily is an online retailer. Zulily’s merchandise includes women’s, children’s and men’s apparel, children’s merchandise and other products, such as kitchen accessories and home decor. Zulily launches a range of flash sales events. These events feature thousands of product styles from different vendors and typically last for over 70 h ours. Zulily acquires new e-mail subscribers through a set o! f paid an! d unpaid marketing channels, including affiliate channels and partners, customer referrals, direct navigation, display advertising, key word search campaigns, search engine optimization, social media and television ads. Zulily acquires customers once through paid and unpaid sources, and then drives engagement and repeat purchases from those customers over a long period of time through the sending of daily e-mails and mobile push communications.

The Company competes with Amazon, Travelocity, Priceline, American Express and Navigant International.

Advisors’ Opinion:

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

5 Best Sliver Stocks To Own Right Now: 1-800 FLOWERS.COM Inc.(FLWS)

1-800-Flowers.com, Inc. together with its subsidiaries, operates as a florist and gift retailer in the United States. The company offers a range of products, including fresh-cut flowers, floral arrangements and plants, gifts, popcorn, gourmet foods and gift baskets, cookies, chocolates, candy, and wine through its telephonic and online sales channels, company-owned and operated retail floral stores, and franchised stores. It provides gourmet gifts, such as popcorn and specialty treats through thepopcornfactory.com; cookies and baked gifts through cheryls.com; chocolates and confections through fanniemay.com and harrylondon.com; gift baskets and towers through 1800baskets.com; Celebrations brand party ideas and planning tips through celebrations.com; and customizable invitations, announcements, and greeting cards through finestationery.com. As of July 3, 2011, the company operated 2 floral retail stores, 1 fulfillment center, and approximately 100 franchised stores located within the United States. It has strategic online relationships with Facebook, Google, AOL, Yahoo!, and Microsoft. The company was founded in 1976 and is headquartered in Carle Place, New York.

Advisors’ Opinion:

  • [By Wayne Duggan]

    U.S. retailers performed poorly during the Christmas holiday season, but companies in the Valentine’s Day business are hoping that Americans will spend generously in the name of love this year. These names include flower delivery company 1-800-Flowers.Com Inc (NASDAQ: FLWS), L Brands Inc (NYSE: LB) (owner of both Victoria’s Secret and Bath & Body Works), Church & Dwight Co., Inc. (NYSE: CHD) (owner of Trojan brand condoms), candy giant Hershey Co (NYSE: HSY) and luxury jeweler Tiffany & Co. (NYSE: TIF).

5 Best Sliver Stocks To Own Right Now: ZIOPHARM Oncology Inc(ZIOP)

ZIOPHARM Oncology, Inc., incorporated on May 16, 2005, is a biopharmaceutical company. The Company is seeking to acquire, develop and commercialize, on its own or with partners, a portfolio of cancer therapies through synthetic immuno-oncology. The Company’s clinical-stage product candidate, Ad-RTS-IL-12, is used with the oral activator veledimex. Its Ad-RTS-IL-12 + veledimex uses gene delivery system to produce interleukin-12 (IL-12), a potent, naturally occurring anti-cancer protein. The Company’s initial drug candidate being developed using the synthetic immuno-oncology platform is Ad-RTS-IL-12 + veledimex.

The Company in collaboration with Intrexon Corporation is focused on chimeric antigen receptor T cell (CAR+ T) products. The Company in collaboration with Intrexon plans to develop treatments for graft-versus-host disease (GvHD), a major complication of allogeneic hematopoietic stem-cell transplantation (HSCT), which impairs the quality of life and survi val of many recipients. Allogeneic HSCT is used for the treatment of various diseases, including hematological malignancies, immunological deficiencies, as well as non-malignant conditions. Approximately 40 to 60% of HSCT recipients develop GvHD, either acute or chronic, when immune (graft) cells in a transplant patient recognize their engrafted host as foreign and attack the patient’s (host) cells. Immunosuppressive agents and systemic steroids routinely used to treat GvHD have limited efficacy and toxicity. Human studies have shown that administration of low-dose subcutaneous IL-2 in patients with steroid-refractory GvHD acts through Tregs to ameliorate its manifestations.

Ad-RTS-IL-12 + veledimex

The Company’s Ad-RTS-IL-12 + veledimex has been evaluated in two Phase II studies, the first for the treatment of metastatic melanoma, and the second for the treatment of unresectable recurrent or metastatic breast cancer. The Company is evaluating Ad-RT S-IL-12 + veledimex, in brain cancer and breast cancer. It h! as developed an adenoviral vector, Ad-RTS-IL-12, administered intratumorally under the control of the RheoSwitch Therapeutic System (RTS) expression platform. Gene expression and subsequent IL-12 protein production is tightly controlled by the activator ligand veledimex.

Ad-RTS-IL-12 + veledimex for malignant glioma

The Company has initiated the Phase I study for malignant glioma. The Food and Drug Administration (FDA) granted orphan drug designation of Ad-RTS-IL-12 + veledimex for the treatment of malignant glioma.

Ad-RTS-IL-12 + veledimex for metastatic breast cancer and melanoma

The Company has completed the Phase II monotherapy studies in melanoma and breast cancer using Ad-RTS-IL-12 + veledimex. The Company has initiated a Phase Ib/II study of Ad-RTS-hIL-12 + veledimex following chemotherapy for the treatment of patients with locally metastatic breast cancer.

The Company competes with Novartis/University o f Pennsylvania, Bluebird bio/Celgene/Baylor College of Medicine, Kite Pharma/National Cancer Institute, Juno Therapeutics/Fred Hutchinson Cancer Research Center/Memorial Sloan-Kettering Cancer Center/Seattle Children’s Research Institute, Cellectis/Pfizer, Adaptimmune/GSK, Celgene, NantKwest, Amgen, AstraZeneca, Bristol-Myers, Incyte, Merck and Roche.

Advisors’ Opinion:

  • [By Monica Gerson]

    ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) rose 10.43 percent to $7.73 in pre-market trading after the company offered data highlighting favorable interim survival results with Ad-RTS-hIL-12 in brain cancer.